University and Pharma company forge new cooperation  

DTU and Leo join forces to seek new revenue streams

National newspaper Berlingske Tidende reports today that the Technical University of Denmark (DTU) and Danish pharmaceutical company Leo have initiated a cooperation model which could result long term in new forms of drug treatment as well as major new revenue streams for both players.

That is the driving force behind QSI Pharma A/S, a DTU based company with 2 researchers from the university as the idea generators. Leo Incubator has invested DKK 12 million in QSI to provide administrative backup and management know-how while DTU has a 15% stake in QSI, renting space to the company and employing the researchers. The idea is to enable the QSI researchers to concentrate fully on the development of potential blockbusters by relieving them of time-consuming business administration tasks.

QSI is currently researching into creating novel types of antibiotic that will avoid resistance problems.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×